Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Regulatory News (MCS)

  • There is currently no data for MCS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

26 Jan 2021 08:31

RNS Number : 8966M
GoldmanSachs International
26 January 2021
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MCCARTHY & STONE PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

MASTIFF BIDCO LIMITED (A COMPANY INDIRECTLY WHOLLY-OWNED BY LONE STAR REAL ESTATE FUND VI)

(d) Date dealing undertaken:

25 January 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

8p ordinary

Purchases

22,995

1.1990 GBP

1.1980 GBP

8p ordinary

Sales

23,546

1.1982 GBP

1.1980 GBP

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

26 January 2021

Contact name:

Paul Grainger and Kashif Rafiq

Telephone number:

+44(20) 7552 9835 / +44(20) 7051 0547

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGIGDBBXDDGBL
Date   Source Headline
31st Jul 20208:23 amRNSDirectorate Change
29th Jul 20205:41 pmRNSHolding(s) in Company
15th Jul 20207:01 amRNSDirectorate Change
15th Jul 20207:00 amRNSHalf Year Results
3rd Jul 20209:00 amRNSNotice of Interim Results
22nd Jun 20204:11 pmRNSHolding(s) in Company
9th Jun 20204:18 pmRNSHolding(s) in Company
2nd Jun 20207:00 amRNSCOVID-19 Business Update
1st Jun 20209:30 amRNSDirector/PDMR Shareholding
28th May 202012:13 pmRNSDirector/PDMR Shareholding
19th May 20201:11 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirectorate Change
1st May 20207:00 amRNSTotal Voting Rights
1st May 20207:00 amRNSHolding(s) in Company
30th Apr 20205:56 pmRNSSale of assets to Waverstone LLP
29th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
7th Apr 202011:41 amRNSAdditional Listing
2nd Apr 20204:28 pmRNSDirector/PDMR Shareholding
27th Mar 20202:37 pmRNSHolding(s) in Company
25th Mar 202011:14 amRNSResults of Annual General Meeting
25th Mar 20207:00 amRNSAGM & Business Update
24th Mar 20201:37 pmRNSHolding(s) in Company
20th Mar 20204:17 pmRNSAnnual General Meeting and Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 202010:56 amRNSCOVID-19 update
12th Mar 202011:44 amRNSHolding(s) in Company
2nd Mar 20209:14 amRNSTotal Voting Rights
19th Feb 202010:03 amRNSAnnual Financial Report
11th Feb 202010:22 amRNSDirector/PDMR Shareholding
7th Feb 20208:32 amRNSDirector/PDMR Shareholding
3rd Feb 20201:50 pmRNSHolding(s) in Company
3rd Feb 20209:16 amRNSBlock listing Interim Review
3rd Feb 20209:04 amRNSTotal Voting Rights
29th Jan 20203:45 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSFull Year Results
15th Jan 202010:40 amRNSDirector Declaration
13th Jan 20207:00 amRNSNotice of Results
10th Jan 20207:00 amRNSAppointment - General Counsel & Company Secretary
9th Jan 20202:35 pmRNSHolding(s) in Company
2nd Jan 202010:30 amRNSTotal Voting Rights
12th Dec 20199:12 amRNSDirectorate Change
15th Nov 20198:55 amRNSDirector/PDMR Shareholding
14th Nov 20198:06 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSHolding(s) in Company
7th Nov 20199:09 amRNSHolding(s) in Company
7th Nov 20197:00 amRNSFY19 Trading Update
1st Nov 20198:27 amRNSDirectorate Change
24th Oct 20198:05 amRNSHolding(s) in Company
22nd Oct 20193:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.